Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Holzer

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 7, 2017
Cross-Platform Comparison of Computer-assisted Image Analysis Quantification of In Situ mRNA Hybridization in Investigative PathologyTimothy R Holzer, Jeffrey C Hanson, Erin M Wray, et al.
Journal of Environmental Radioactivity|May 2, 2016
Long-term behavior of (90)Sr and (137)Cs in the environment: Case studies in SwitzerlandJ A Corcho-Alvarado, B Balsiger, H Sahli, et al.
Scientific Reports|June 20, 2020
Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung CancerDaniel C Liebler, Timothy R Holzer, Alexander Haragan, et al.
Investigational New Drugs|February 6, 2017
Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumorsPatricia M LoRusso, Mrinal Gounder, Shadia I Jalal, et al.
Journal of Translational Medicine|March 19, 2022
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimabJonathan T Sims, Josh Poorbaugh, Ching-Yun Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancerDavid S Hong, Razelle Kurzrock, Yun Oh, et al.
Journal of Neuropathology and Experimental Neurology|September 19, 2025
Convolutional neural network-derived neurofibrillary tangle classifiers: Investigative tools to identify maturation levels and explore post-translational modifications using laser capture microdissection coupled mass spectrometryCouger Jimenez Jaramillo, Drew Nedderman, Erpan Ahat, et al.
Archives of Pathology & Laboratory Medicine|July 7, 2021
Analytical Accuracy of RET Fusion Detection by Break-Apart Fluorescence In Situ HybridizationJessica A Baker, Anthony N Sireci, Narasimha Marella, et al.
Plos One|November 19, 2013
Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lungTimothy R Holzer, Angie D Fulford, Drew M Nedderman, et al.
JAMA|January 21, 2021
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical TrialRobert L Gottlieb, Ajay Nirula, Peter Chen, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 7, 2017
Cross-Platform Comparison of Computer-assisted Image Analysis Quantification of In Situ mRNA Hybridization in Investigative PathologyTimothy R Holzer, Jeffrey C Hanson, Erin M Wray, et al.
Journal of Environmental Radioactivity|May 2, 2016
Long-term behavior of (90)Sr and (137)Cs in the environment: Case studies in SwitzerlandJ A Corcho-Alvarado, B Balsiger, H Sahli, et al.
Scientific Reports|June 20, 2020
Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung CancerDaniel C Liebler, Timothy R Holzer, Alexander Haragan, et al.
Investigational New Drugs|February 6, 2017
Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumorsPatricia M LoRusso, Mrinal Gounder, Shadia I Jalal, et al.
Journal of Translational Medicine|March 19, 2022
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimabJonathan T Sims, Josh Poorbaugh, Ching-Yun Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancerDavid S Hong, Razelle Kurzrock, Yun Oh, et al.
Journal of Neuropathology and Experimental Neurology|September 19, 2025
Convolutional neural network-derived neurofibrillary tangle classifiers: Investigative tools to identify maturation levels and explore post-translational modifications using laser capture microdissection coupled mass spectrometryCouger Jimenez Jaramillo, Drew Nedderman, Erpan Ahat, et al.
Archives of Pathology & Laboratory Medicine|July 7, 2021
Analytical Accuracy of RET Fusion Detection by Break-Apart Fluorescence In Situ HybridizationJessica A Baker, Anthony N Sireci, Narasimha Marella, et al.
Plos One|November 19, 2013
Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lungTimothy R Holzer, Angie D Fulford, Drew M Nedderman, et al.
JAMA|January 21, 2021
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical TrialRobert L Gottlieb, Ajay Nirula, Peter Chen, et al.
Pageof 6